House dust mite allergy immunotherapy - Allergy Therapeutics
Alternative Names: Acarovac; Acarovac Plus; Dermatophagoides-pteronyssinus-allergen-extract-Allergy-Therapeutics; Dermatophagoides-pteronyssinus-allergy-immunotherapy-Allergy-Therapeutics; HDM allergy vaccine - Allergy Therapeutics; House dust mite allergy vaccine - Allergy Therapeutics; Mite-allergoid-Allergy-TherapeuticsLatest Information Update: 16 Jul 2016
At a glance
- Originator Allergy Therapeutics
- Class Allergens; Allergy immunotherapies; Antiallergics
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Allergic rhinitis
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Allergic-rhinitis in United Kingdom (SC)
- 01 Mar 2013 Acarovac Plus is available on a Named Patient Access Programme for the treatment of allergic rhinitis in Spain
- 01 Mar 2013 Launched for Allergic rhinitis in Spain (SC)